Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter ‐defibrillator
ConclusionOur findings from a large cohort of ICD recipients enrolled in landmark clinical trials show that device detected AF and VT/VF can be used to identify patients with increased risk for CHF exacerbation and mortality. These findings suggest a need for early intervention in CHF patients who develop device-detected atrial and ventricular tachyarrhythmias.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Hassan Abbas,
Arwa Younis,
Ilan Goldenberg,
Scott McNitt,
Mehmet K. Aktas,
Chadi Tabaja,
Amole Ojo Tags: ORIGINAL ARTICLE Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Cardiovascular | Clinical Trials | Congestive Heart Failure | Heart | Heart Failure | Study | Ventricular Tachycardia